Cited 0 times in
Evaluating the Modified Patient Health Questionnaire-2 and Insomnia Severity Index-2 for Daily Digital Screening of Depression and Insomnia: Validation Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이덕종 | - |
dc.contributor.author | 이산 | - |
dc.date.accessioned | 2023-07-12T02:43:05Z | - |
dc.date.available | 2023-07-12T02:43:05Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/195378 | - |
dc.description.abstract | Background: The Patient Health Questionnaire-2 (PHQ-2) and Insomnia Severity Index-2 (ISI-2) are screening assessments that reflect the past 2-week experience of depression and insomnia, respectively. Retrospective assessment has been associated with reduced accuracy owing to recall bias. Objective: This study aimed to increase the reliability of responses by validating the use of the PHQ-2 and ISI-2 for daily screening. Methods: A total of 167 outpatients from the psychiatric department at the Yongin Severance Hospital participated in this study, of which 63 (37.7%) were male and 104 (62.3%) were female with a mean age of 35.1 (SD 12.1) years. Participants used a mobile app ("Mental Protector") for 4 weeks and rated their depressive and insomnia symptoms daily on the modified PHQ-2 and ISI-2 scales. The validation assessments were conducted in 2 blocks, each with a fortnight response from the participants. The modified version of the PHQ-2 was evaluated against the conventional scales of the Patient Health Questionnaire-9 and the Korean version of the Center for Epidemiologic Studies Depression Scale-Revised. Results: According to the sensitivity and specificity analyses, an average score of 3.29 on the modified PHQ-2 was considered valid for screening for depressive symptoms. Similarly, the ISI-2 was evaluated against the conventional scale, Insomnia Severity Index, and a mean score of 3.50 was determined to be a valid threshold for insomnia symptoms when rated daily. Conclusions: This study is one of the first to propose a daily digital screening measure for depression and insomnia delivered through a mobile app. The modified PHQ-2 and ISI-2 were strong candidates for daily screening of depression and insomnia, respectively. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | JMIR Publications | - |
dc.relation.isPartOf | JMIR MENTAL HEALTH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Evaluating the Modified Patient Health Questionnaire-2 and Insomnia Severity Index-2 for Daily Digital Screening of Depression and Insomnia: Validation Study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Psychiatry (정신과학교실) | - |
dc.contributor.googleauthor | Jae Won Oh | - |
dc.contributor.googleauthor | Sun Mi Kim | - |
dc.contributor.googleauthor | Deokjong Lee | - |
dc.contributor.googleauthor | Nak-Hoon Son | - |
dc.contributor.googleauthor | Jinsun Uh | - |
dc.contributor.googleauthor | Ju Hong Yoon | - |
dc.contributor.googleauthor | Yukyung Choi | - |
dc.contributor.googleauthor | San Lee | - |
dc.identifier.doi | 10.2196/45543 | - |
dc.contributor.localId | A04869 | - |
dc.contributor.localId | A05001 | - |
dc.relation.journalcode | J03876 | - |
dc.identifier.eissn | 2368-7959 | - |
dc.identifier.pmid | 37213186 | - |
dc.subject.keyword | ISI-2 | - |
dc.subject.keyword | Insomnia Severity Index | - |
dc.subject.keyword | PHQ-2 | - |
dc.subject.keyword | Patient Health Questionnaire-2 | - |
dc.subject.keyword | depression | - |
dc.subject.keyword | insomnia | - |
dc.subject.keyword | mobile health | - |
dc.subject.keyword | mobile phone | - |
dc.contributor.alternativeName | Lee, Deok Jong | - |
dc.contributor.affiliatedAuthor | 이덕종 | - |
dc.contributor.affiliatedAuthor | 이산 | - |
dc.citation.volume | 10 | - |
dc.citation.startPage | e45543 | - |
dc.identifier.bibliographicCitation | JMIR MENTAL HEALTH, Vol.10 : e45543, 2023-05 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.